Skip to Main Content

Author Details

Raymond H Kim
Cardiac Genome Clinic, The Hospital for Sick Children
2005
145
33
PMIDPaper TitleJournal TitlePublished Year
36376761SCIP: software for efficient clinical interpretation of copy number variants detected by whole-genome sequencing.Hum Genet2023
37481477Germline whole genome sequencing in adults with multiple primary tumors.Fam Cancer2023
37217257A model for the return and referral of all clinically significant secondary findings of genomic sequencing.J Med Genet2023
36974392Oncologist-led germline genetic testing for uveal melanoma.Ophthalmic Genet2023
36478486Patient-reported outcomes associated with reflex BRCA1/2 tumor and subsequent germline panel genetic testing for high-grade serous ovarian cancer.J Genet Couns2023
36919843How do members of the public expect to use variants of uncertain significance in their health care? A population-based survey.Genet Med2023
36617168Developing a disease-specific annotation protocol for VHL gene curation using Hypothes.is.Database (Oxford)2023
36564171Development of a comprehensive approach to adult hereditary cancer testing in Ontario.J Med Genet2023
36416899Variation in knee balance as a function of hip-knee-ankle angle and joint line obliquity in robotic assisted total knee arthroplasty.Int Orthop2023
36701047FLCN-Driven Functional Adrenal Cortical Carcinoma with High Mitotic Tumor Grade: Extending the Endocrine Manifestations of Birt-Hogg-Dubé Syndrome.Endocr Pathol2023
36373660CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase.Nucleic Acids Res2023
33067353Stay at home: implementation and impact of virtualising cancer genetic services during COVID-19.J Med Genet2022
35586610Use of Cannabis Does Not Decrease Opioid Consumption in Patients Who Underwent Total Joint Arthroplasty.Arthroplast Today2022
35739291A comprehensive genomic reporting structure for communicating all clinically significant primary and secondary findings.Hum Genet2022
35840934LZTR1 molecular genetic overlap with clinical implications for Noonan syndrome and schwannomatosis.BMC Med Genomics2022
35475554Large scale genotype- and phenotype-driven machine learning in Von Hippel-Lindau disease.Hum Mutat2022
35732815An appraisal of genetic testing for prostate cancer susceptibility.NPJ Precis Oncol2022
35469975A Model for the Integration of Genome Sequencing Into a Pediatric Cardiology Clinic.Can J Cardiol2022
35624339A community approach to the cancer-variant-interpretation bottleneck.Nat Cancer2022
35487723Genetics Adviser: a protocol for a mixed-methods randomised controlled trial evaluating a digital platform for genetics service delivery.BMJ Open2022
35418215Reflex BRCA1 and BRCA2 tumour genetic testing for high-grade serous ovarian cancer: streamlined for clinicians but what do patients think?Hered Cancer Clin Pract2022
35385106"Game Changer": Health Professionals' Views on the Clinical Utility of Circulating Tumor DNA Testing in Hereditary Cancer Syndrome Management.Oncologist2022
36112138Clinical implementation of genetic testing in adults for hereditary hematologic malignancy syndromes.Genet Med2022
33776058Widening the lens of actionability: A qualitative study of primary care providers' views and experiences of managing secondary genomic findings.Eur J Hum Genet2022
35012974Brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed non-serous, non-mucinous ovarian cancers.Int J Gynecol Cancer2022
35219592Trio genome sequencing for developmental delay and pediatric heart conditions: A comparative microcost analysis.Genet Med2022
35180879GeneTerpret: a customizable multilayer approach to genomic variant prioritization and interpretation.BMC Med Genomics2022
35304467VHL mosaicism: the added value of multi-tissue analysis.NPJ Genom Med2022
34768014Challenges and practical solutions for managing secondary genomic findings in primary care.Eur J Med Genet2022
32581083Exome and genome sequencing in adults with undiagnosed disease: a prospective cohort study.J Med Genet2021
33744472Sensitization to Implant Components Is Associated with Joint Replacement Failure: Identification and Revision to Nonallergenic Hardware Improves Outcomes.J Allergy Clin Immunol Pract2021
33718561Can <i>TP53</i> variant negative be high-grade serous ovarian carcinoma? A case series.Gynecol Oncol Rep2021
33653629Outpatient Total Joint Arthroplasty: The New Reality.J Arthroplasty2021
33917963A Comparison of Patient-Reported Outcomes Following Consent for Genetic Testing Using an Oncologist- or Genetic Counselor-Mediated Model of Care.Curr Oncol2021
33633277Dj1 deficiency protects against atherosclerosis with anti-inflammatory response in macrophages.Sci Rep2021
33858678The Prevent Ovarian Cancer Program (POCP): Identification of women at risk for ovarian cancer using complementary recruitment approaches.Gynecol Oncol2021
34537903Patient and public preferences for being recontacted with updated genomic results: a mixed methods study.Hum Genet2021
34037732Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting.JAMA Netw Open2021
33983630Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancer.Cancer2021
34171218The evolving role of germline genetic testing and management in prostate cancer: Report from the Princess Margaret Cancer Centre international retreat.Can Urol Assoc J2021
34282142Incidental findings from cancer next generation sequencing panels.NPJ Genom Med2021
33030818Tumor and germline next generation sequencing in high grade serous cancer: experience from a large population-based testing program.Mol Oncol2021
33478752Understanding the clinical implication of mismatch repair deficiency in endometrioid endometrial cancer through a prospective study.Gynecol Oncol2021
32892247Beyond medically actionable results: an analytical pipeline for decreasing the burden of returning all clinically significant secondary findings.Hum Genet2021
32252413Genomics of MPNST (GeM) Consortium: Rationale and Study Design for Multi-Omic Characterization of NF1-Associated and Sporadic MPNSTs.Genes (Basel)2020
33110418Genes and Pathways Implicated in Tetralogy of Fallot Revealed by Ultra-Rare Variant Burden Analysis in 231 Genome Sequences.Front Genet2020
33083010Early-onset renal cell carcinoma in <i>PTEN</i> harmatoma tumour syndrome.NPJ Genom Med2020
33082239Tumor site discordance in mismatch repair deficiency in synchronous endometrial and ovarian cancers.Int J Gynecol Cancer2020
32809219Performance characteristics of screening strategies to identify Lynch syndrome in women with ovarian cancer.Cancer2020
32674931Year 1: Experiences of a tertiary cancer centre following implementation of reflex BRCA1 and BRCA2 tumor testing for all high-grade serous ovarian cancers in a universal healthcare system.Gynecol Oncol2020
  • 1 - 50 of 145

Recommended Authors

University of California Los Angeles
Career Start Year 2013
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 2012
Number of shared co-authors 0
Center for Interventional Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year 2011
Number of shared co-authors 0
The University of North Carolina at Chapel Hill
Career Start Year 2009
Number of shared co-authors 20
Yale School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Center for Innovative Design and Analysis, University of Colorado, Aurora CO.
Career Start Year 2008
Number of shared co-authors 0
Oregon Health & Science University (OHSU)
Career Start Year 2008
Number of shared co-authors 1
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2008
Number of shared co-authors 2
Garvan Institute of Medical Research
Career Start Year 2004
Number of shared co-authors 3
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 3
Clinical Genetics Branch, National Cancer Institute
Career Start Year 2003
Number of shared co-authors 11
Center for Clinical and Translational Science, Mayo Clinic
Career Start Year 2002
Number of shared co-authors 1
University of Colorado Anschutz Medical Campus
Career Start Year 2001
Number of shared co-authors 0
Guy's and St Thomas' NHS Foundation Trust, Evelina Children's Hospital
Career Start Year 2001
Number of shared co-authors 1
Mayo Clinic College of Medicine and Science
Career Start Year 2001
Number of shared co-authors 9
University Hospital Zurich
Career Start Year 2001
Number of shared co-authors 0
Northwestern University Feinberg School of Medicine
Career Start Year 1998
Number of shared co-authors 2
Guy's and St Thomas' NHS Foundation Trust
Career Start Year 1998
Number of shared co-authors 3
David Geffen School of Medicine at University of California los angeles
Career Start Year 1997
Number of shared co-authors 0
Harvard Medical School
Career Start Year 1997
Number of shared co-authors 2
David Geffen School of Medicine, University of California los angeles
Career Start Year 1997
Number of shared co-authors 3
College of Medicine, University of South Florida
Career Start Year 1995
Number of shared co-authors 5
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 16
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 1992
Number of shared co-authors 1
Boston University School of Medicine
Career Start Year 1991
Number of shared co-authors 1
National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 0
Department of Rare Skeletal Disorders - IRCCS Istituto Ortopedico Rizzoli
Career Start Year 1990
Number of shared co-authors 0
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Career Start Year 1986
Number of shared co-authors 8
University of Washington Medical Center
Career Start Year 1985
Number of shared co-authors 22

Collaborators

Toronto General Hospital
Co-authored papers 14
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 13
University of British Columbia
Co-authored papers 9
University of Toronto.
Co-authored papers 8
Mount Sinai Hospital
Co-authored papers 7
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 7
Co-authored papers 6
University of Toronto
Co-authored papers 6
The Hospital for Sick Children
Co-authored papers 6
Co-authored papers 5
University of Toronto
Co-authored papers 5
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Co-authored papers 5
University Medical Center Utrecht
Co-authored papers 5
McDonnell Genome Institute, Washington University in St Louis School of Medicine
Co-authored papers 4
Hospital for Sick Children
Co-authored papers 4
University Health Network
Co-authored papers 4
University of Nevada
Co-authored papers 4
University of Toronto
Co-authored papers 4
Washington University School of Medicine
Co-authored papers 4
Baylor College of Medicine
Co-authored papers 4
Washington University
Co-authored papers 4
Washington University
Co-authored papers 4
McDonnell Genome Institute, Washington University in St Louis School of Medicine
Co-authored papers 4
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 3
Innovation Center for Biomedical Informatics, Georgetown University Medical Center
Co-authored papers 3
Washington University
Co-authored papers 3
Princess Margaret Cancer Centre, University Avenue
Co-authored papers 3
Toronto General Hospital, University Health Network, University of Toronto
Co-authored papers 3
McDonnell Genome Institute, Washington University in St Louis School of Medicine
Co-authored papers 3
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 3